How to Track Provider Profitability at a Medical Spa

Provider profitability at a medical spa equals the provider's revenue minus their injectable COGS and compensation cost. A nurse practitioner earning $132,050 in base salary needs to generate at least $330,000 in annual injectable and treatment revenue at a 40% COGS load to clear a 20% contribution margin.

Ask most medical spa owners which of their injectors is the most profitable and they will tell you who generates the most revenue. That is the wrong number. Revenue without the cost structure underneath it is not profitability, it is a leaderboard.

The provider generating $600,000 in annual revenue on a $180,000 compensation package with 45% injectable COGS is delivering less margin than the provider at $380,000 in revenue with a $110,000 package and a 35% COGS load. The calculation is straightforward. Most practices have never done it.

What Is Provider Profitability at a Medical Spa?

Provider profitability is the contribution margin a provider generates after subtracting the two costs directly attributable to their work: injectable product cost (COGS) and direct compensation. The formula takes three inputs: provider revenue, provider COGS, and provider compensation.

Rent, software, marketing, and management are shared overhead. Do not assign them to a provider for this calculation.

Contribution margin percent = (Revenue - COGS - Direct Compensation) / Revenue x 100

This is the metric that tells you whether a provider is generating enough margin to cover their share of practice overhead and contribute to net profit. A 25-35% contribution margin is a healthy operating target. Below 20% is a warning sign. At 15% or lower, the provider's direct costs are consuming most of the gross margin they produce, and there is very little left before overhead is allocated.

$132,050
Mean annual NP wage (all roles, national)
Source: Bureau of Labor Statistics, Occupational Employment and Wage Statistics, May 2024.

How Do You Calculate Revenue per Provider at a Med Spa?

Provider revenue attribution requires your booking system, not QuickBooks. Zenoti, Boulevard, AestheticsPro, and PatientNow all support revenue reports filtered by provider or injector. Pull the date range you want, select each provider, and export the total revenue attributed to their patient treatments. This is the starting number for every profitability calculation.

Two practical notes on data quality. First, if your booking system allows a provider to be listed as the booking provider versus the treating provider, use the treating provider for revenue attribution. The person who performed the treatment earned that revenue.

Second, revenue from packages and pre-paid services should be recognized at the time of service delivery, not at the time of package purchase. If a patient pre-paid for a five-session package, the revenue for each session belongs to the provider who delivered it. See the discussion of deferred revenue in medical spas for why this distinction matters for practice-level reporting as well.

According to Zenoti (March 2026), the average ticket at a medical spa runs $164 per treatment. A provider seeing 40 patients per week at that average generates approximately $341,120 in annual revenue. Whether that is profitable depends entirely on the COGS and compensation structure, not the volume alone.

How Do Injectable COGS Affect Provider Profitability?

Injectable COGS is the single largest variable cost directly tied to a provider's work. Every unit of Botox, every syringe of Juvederm, every vial of Sculptra drawn and administered by a provider represents product cost that comes directly out of the revenue that provider generated.

The practice paid Allergan or Galderma for that product. That cost belongs to the provider who used it, not to a general expense pool.

Allocating injectable COGS by provider requires either a booking system that tracks product usage at the provider and patient level, or a manual reconciliation using treatment notes and vendor invoices. The booking system route is faster and more accurate if your system supports it. The manual route is labor-intensive but doable for smaller practices.

The math on why this matters: a 10-point shift in COGS percentage on $400,000 of injectable revenue changes gross margin by $40,000 before compensation. A provider running 45% injectable COGS instead of 35% on $400,000 in revenue costs the practice $40,000 in gross margin annually.

That is not an accounting footnote. That is the difference between a profitable provider and a breakeven one. The deeper framework for this calculation is in how to calculate your real injectable gross margin.

$164
Average ticket size at medical spas
Source: Zenoti, March 2026. Staff utilization average: 47%. Top earners: 78%.

What Compensation Model Produces the Best Provider Margin?

Three compensation models are common for medical spa injectors, each with a different margin profile and a different risk allocation between provider and practice.

Straight salary

The provider receives a fixed annual salary regardless of revenue generated. The practice absorbs all volume risk.

Compensation cost is predictable and does not scale with revenue, which means contribution margin improves as the provider generates more volume.

The downside: no direct financial incentive for the provider to build their book of business or optimize patient throughput. Straight salary is most appropriate for new providers still building patient volume, where commission structure would not yet generate meaningful incremental pay.

Base salary plus revenue commission

The most common structure at established practices. The provider receives a base salary to cover fixed living expenses and a commission on revenue generated above a defined threshold. Commission rates typically run 20-30% of revenue above the break-even point for the provider's compensation.

This aligns provider incentives with revenue growth while keeping the practice's fixed cost exposure bounded.

The threshold should be set so that the commission only kicks in after the provider has covered their base cost plus COGS from their revenue. Consult employment counsel before implementing this model in your state, as commission structures for licensed healthcare providers carry compliance requirements that vary by jurisdiction.

Pure commission

The provider is paid a percentage of the revenue they generate, with no base salary. This is uncommon for injectors in the medical spa setting and carries meaningful legal risk.

Some states classify commission-only arrangements for licensed healthcare providers as misclassifying an employee as an independent contractor, which triggers wage and hour liability. Do not implement a pure commission model without employment law counsel specific to your state.

Model Fixed Cost Risk Incentive Alignment Compliance Complexity
Straight salary High (practice) Low Low
Base + commission Shared High Moderate
Pure commission Low (practice) High High

How Do You Build a Provider Profitability Report in QuickBooks?

QuickBooks Online does not natively attribute revenue to individual providers.

Building a provider profitability report requires combining data from two systems: revenue and COGS from the booking system and payroll exports, and compensation from your payroll provider or payroll records. The QuickBooks piece handles the chart of accounts structure, but the actual provider-level calculation happens in a spreadsheet or a dedicated reporting layer built on top of QuickBooks.

The setup that works: use Classes in QuickBooks to tag each revenue transaction with the treating provider. Every injectable service invoice gets tagged with the provider class.

Every vendor invoice (Allergan, Galderma) gets tagged to the same provider class if you know which provider used the product. Payroll entries get tagged to the relevant provider class for compensation cost. A QuickBooks Profit and Loss by Class report then produces the raw inputs for a provider contribution margin calculation by period.

In practice, most medical spas do not have the QuickBooks setup to pull this cleanly from a single report. The more realistic approach is a monthly or quarterly provider profitability worksheet that imports three data pulls: provider revenue from the booking system, provider COGS from vendor invoice reconciliation, and provider compensation from payroll records.

The calculation itself takes under 30 minutes once the data is assembled. Building the process to assemble the data consistently is the work.

Not knowing which injector is profitable means every compensation decision, scheduling choice, and retention conversation runs on the wrong data. That number takes under an hour to produce. Most practices have never produced it.

Illustrative example: NP injector profitability calculation

Illustrative example only. Figures use BLS and Zenoti published benchmarks.
Annual base salary (BLS NP mean, May 2024): $132,050
Employer payroll taxes + benefits (estimated 15% loaded cost): $19,808
Total annual compensation cost: $151,858
 
Target contribution margin: 25%
Injectable COGS load: 40%
 
Solving for required revenue (R):
0.25R = R - 0.40R - $151,858
0.25R = 0.60R - $151,858
$151,858 = 0.35R
Required revenue = $151,858 / 0.35 = approximately $434,000/year
 
At $164 avg ticket (Zenoti, March 2026): approximately 2,646 treatments/year
Per week (52 weeks): approximately 51 treatments/week
 
Reality check: average staff utilization at medical spas is 47% (Zenoti). Most NPs see 35-45 patients per week at standard utilization. 51 treatments/week sits at the upper edge of what a typical full-time schedule supports. Achieving 25% contribution margin at BLS mean salary and 40% COGS requires above-average utilization, above-average ticket, or a below-average compensation package.

This example illustrates why provider compensation decisions cannot be made on gut feel or competitive market comparisons alone. A $132,050 NP salary is the national BLS mean.

In a major metro market, that number is higher. Against a $164 average ticket and a 40% COGS load, the math produces a narrow margin that depends heavily on patient volume. Practices that hire at market rate without modeling the revenue requirement first frequently find themselves with a labor cost problem by the end of the first year.

For context on the injectable cost side of this equation, Allergan reported global Botox Cosmetic net revenues of $2.602 billion for the period covered in their February 2026 filing, and Galderma reported net sales of $5.207 billion in 2025, up 17.7% at constant currency per their March 2026 results. The injectable market is large and growing, but per-unit vendor pricing does not compress over time. COGS management at the provider level is a margin lever practices control directly.

Provider profitability reports built into your monthly close.

Spa Ledger builds and delivers a provider contribution margin report with your monthly P&L. Revenue pulled from your booking system. COGS reconciled against vendor invoices. Compensation loaded from payroll. One report, every month, no assembly required. First month is free.

Reserve Your First Month

Frequently asked questions

Provider profitability equals provider revenue minus injectable COGS minus direct compensation cost. The result is the provider contribution margin. Expressed as a percentage: contribution margin divided by provider revenue. The target range is 25-35% after COGS and direct compensation. Below 20% means the provider is not generating enough margin to cover their share of practice overhead, and the compensation or pricing structure needs review.
A target contribution margin of 25-35% per injector after subtracting injectable COGS and direct compensation from attributed revenue is a sound operational benchmark. Below 20% is a warning sign that the provider may be priced too low, carrying too high a product cost, or not generating enough treatment volume to justify their compensation structure. Above 40% generally indicates strong pricing and efficient COGS management.
Injectable COGS is the first deduction from provider revenue and has a direct, linear effect on contribution margin. At a 40% COGS load, a provider generating $400,000 in injectable revenue starts with $240,000 in gross margin before compensation. At a 50% COGS load on the same $400,000, gross margin drops to $200,000. A 10-point COGS increase costs $40,000 in gross margin annually, which is why weekly injectable COGS reconciliation matters at the provider level, not just the practice level.
Base salary with a revenue-based commission above a break-even threshold is the most common model for injectors at established practices. Pure straight salary works for newer providers still building a patient base. Pure commission is uncommon for injectors and can create employment law compliance exposure in some states. The right model aligns provider incentives with practice margin goals while meeting state employment requirements. Consult employment counsel before implementing any commission structure for licensed healthcare providers in your state.
QuickBooks Online does not natively track revenue by individual provider. Provider revenue attribution requires either a Class tag on each transaction corresponding to the treating provider, or an integration with your booking system that passes provider-level revenue data into QuickBooks. Most practices pull provider revenue from the booking system (Zenoti, AestheticsPro, Boulevard) and build the profitability calculation in a spreadsheet alongside compensation data from payroll records.